NIH RFA · NIDA · RM1
RFA-DA-25-060: High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)
Reviewed by Dr. Meng ZhaoLast reviewed October 16, 2026Data refreshed October 16, 2026Editorial standards
The purpose of this Funding Opportunity Announcement (FOA) is to support high priority research at the intersection of HIV and substance use. This FOA invites innovative research projects with the potential to open new areas of HIV/AIDS research and/or lead to new avenues for prevention, treatment and cure of HIV among people who use drugs (PWUD). Applications submitted under this FOA are required to have a detailed research plan, preliminary data, and a clear description of the nexus with substance use. This FOA is open to both individual researchers and research teams and includes all areas of research from basic science to clinical and implementation research. All studies must focus on…
- NOFO number
- RFA-DA-25-060
- Type
- RFA
- Activity code
- RM1
- Primary institute
- NIDA · National Institute on Drug Abuse
- Clinical trials
- Optional
- Posted
- Jan 17, 2024
- Opens
- Jul 15, 2024
- Expires
- Mar 6, 2027
Projects funded under RFA-DA-25-060
NIH RePORTER lists 6 projects funded under RFA-DA-25-060 in FY2022–FY2026, with $17.9M in award dollars. Counts include each project's later non-competing years, which keep the original NOFO number.
Projects funded
6
Distinct projects, FY2022–FY2026
New awards
6
Type 1 (new project) award records
NIH funding
$17.9M
Award dollars under RFA-DA-25-060, FY2022–FY2026
Funding by fiscal year
| Fiscal year | Award records | New awards | Funding |
|---|---|---|---|
| FY2022 | 0 | 0 | $0 |
| FY2023 | 0 | 0 | $0 |
| FY2024 | 0 | 0 | $0 |
| FY2025 | 2 | 2 | $4.3M |
| FY2026 | 6 | 4 | $13.6M |
Institutions with the most funding
- University of California, San Francisco$4.7M · 1 project
- Northern California Institute/Res/Edu$4.2M · 1 project
- University of California, San Diego$2.5M · 1 project
- Yale University$2.2M · 1 project
- Father Flanagan's Boys' Home$2.2M · 1 project
- Boston Medical Center$2.1M · 1 project
Funding institutes
- NIDA$17.9M · 8
Activity codes funded
- RM18 records
Most recent new awards
- PREP-TALK: Transforming Hospitalization into a PrEP Engagement Opportunity for People Who Use Drugs (opens NIH RePORTER)
Boston Medical Center · 1RM1DA066198-01 · NIDA · Notice Jul 20, 2026
$2.1MRM1
- Brain-Focused Research on Antiretrovirals and Methamphetamine (Brain-FRAMe) (opens NIH RePORTER)
University of California, San Diego · 1RM1DA066307-01 · NIDA · Notice May 8, 2026
$2.5MRM1
- GEO IMPACT: Geo-Targeted Implementation of a novel Mobile Pharmacy and Clinic healthcare delivery model with Community HeAlth Workers for prevention, Care and Treatment of HIV and substance use (opens NIH RePORTER)
Yale University · 1RM1DA064594-01 · NIDA · Notice Apr 1, 2026
$2.2MRM1
- Pathways from Chronic Methamphetamine Use to Neurological Dysfunction in People with HIV: High-Dimensional Fusion of Systems Biology and Multimodal Neuroimaging (opens NIH RePORTER)
Father Flanagan's Boys' Home · 1RM1DA065022-01 · NIDA · Notice Mar 23, 2026
$2.2MRM1
- Stimulant and Polysubstance use, Inflammation and Sex Effects on Myocardial Disease in HIV (SPISE) (opens NIH RePORTER)
Northern California Institute/Res/Edu · 1RM1DA063351-01 · NIDA · Notice Jul 9, 2025
$2.0MRM1
- In Vivo Imaging and Post-Mortem Study of Methamphetamine Use on Immune Dysfunction and HIV Reservoir Transcription among People with HIV on ART (opens NIH RePORTER)
University of California, San Francisco · 1RM1DA063218-01 · NIDA · Notice Jul 7, 2025
$2.3MRM1
FY2026 closed on September 30, 2026, but NIH keeps posting that year's awards to RePORTER for several weeks. FY2026 figures reflect records available on October 16, 2026 and may rise slightly at the next refresh.
Participating institutes
2 NIH institutes and offices take applications under RFA-DA-25-060. Contact the program officer at the institute that fits your research before applying.
- NIDA · National Institute on Drug Abuse
- none
Related notices
Jan 28, 2026 · NOT-OD-26-029
NIH Removing AIDS Application Due Dates from NOFOs.
Mar 31, 2025
This funding opportunity was updated to align with agency priorities. Carefully reread the full funding opportunity and make any needed adjustments to your application prior to submission.
Apr 4, 2024 · NOT-OD-24-084
Overview of Grant Application and Review Changes for Due Dates on or after January 25, 2025. See Notice NOT-OD-24-084 March 20, 024 - Notice of Pre-Application Technical Assistance Webinar for RFA-DA-25-060.
Aug 31, 2022 · NOT-OD-22-198
Implementation Changes for Genomic Data Sharing Plans Included with Applications Due on or after January 25, 2023. See Notice NOT-OD-22-198.
Aug 5, 2022 · NOT-OD-22-189
Implementation Details for the NIH Data Management and Sharing Policy. See Notice NOT-OD-22-189.
Notices of Special Interest (NOSIs)
NIH has attached 1 NOSI to RFA-DA-25-060; 1 are active. A NOSI flags a topic an institute wants to fund through this NOFO.
- Notice of Pre-Application Technical Assistance Webinar for RFA-DA-25-060NOT-DA-24-019 · NIDA · until Oct 16, 2026
Award terms
- Application types allowed
- NewResubmissionRevision The OER Glossary and the SF424 R&R) Application Guide provide details on these application types. Only those application types listed here are allowed for this NOFO.
- Award budget
- Individual award budgets are not to exceed 1.5M per Fiscal Year in direct costs and should reflect the actual scope of the proposed project.
- Project period
- The scope of the proposed project should determine the project period. The maximum project period is 5 years. NIH grants policies as described in the NIH Grants Policy Statement will apply to the applications submitted and awards made from this NOFO.
- Funds available and number of awards
- NIDA intends to commit 3.0 M in FY 2025, 2026, and 2027 to fund one-two awards.
Summarized from the NOFO text; the full NOFO governs eligibility, budget, and review.
Related NOFOs
- Companion NOFOs: RFA-DA-22-040.
Other open NOFOs for RM1
- RFA-DA-28-011HEAL Initiative: Integrative Management of Chronic Pain and OUD for Whole Recovery (IMPOWR): Research Centers (RM1 Clinical Trial Required)NIDA · next due Jan 26, 2027
- PAR-27-003Collaborative Program Grant for Interdisciplinary Teams (RM1 Clinical Trial Optional)NIGMS · next due Nov 17, 2026
- RFA-NS-27-002BRAIN Initiative: Integrative Team-Research BRAIN Circuits Program - iBCP (RM1 Clinical Trial Not Allowed)NINDS · next due Jun 23, 2027
- PAR-27-024Biomedical Technology Optimization and Dissemination Center (BTOD) (RM1 - Clinical Trial Not Allowed)NIGMS · next due Jan 28, 2027
About this page
GotGrant gathers the NOFO, its participation and change notices, and its NOSIs from the NIH Guide for Grants and Contracts, and counts funded projects from NIH RePORTER by the opportunity number each award was made under. Data refreshed October 16, 2026; the NIH Guide is the authoritative source. See our data methodology.